APA (7th ed.) Citation

G, O., L, C., K, F., B, G., L, C., F, N., & N, J. (2016). Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America. The Journal of infectious diseases, 214(7), 994. https://doi.org/10.1093/infdis/jiw297

Chicago Style (17th ed.) Citation

G, Olivera-Botello, Coudeville L, Fanouillere K, Guy B, Chambonneau L, Noriega F, and Jackson N. "Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America." The Journal of Infectious Diseases 214, no. 7 (2016): 994. https://doi.org/10.1093/infdis/jiw297.

MLA (9th ed.) Citation

G, Olivera-Botello, et al. "Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America." The Journal of Infectious Diseases, vol. 214, no. 7, 2016, p. 994, https://doi.org/10.1093/infdis/jiw297.